# DoD Prostate Cancer, Clinical Consortium Award

Source: https://welltoldgrants.com/grants/ht942525pcrpcca-dod-prostate-cancer-clinical-consortium-award/  
Official notice: https://www.grants.gov/search-results-detail/359060

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 12 awards worth $32.5 million in total. Applications closed on September 2, 2025.

| Field | Value |
|---|---|
| Opportunity number | HT942525PCRPCCA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | September 2, 2025 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 12 |
| Total funding | $32.5 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

Summary: The fiscal year 2025 (FY25) Prostate Cancer Research Program (PCRP) Clinical Consortium Award (CCA) provides support to develop, maintain, and enhance the necessary collaborations and resources to rapidly execute phase 2 and/or phase 2-linked phase 1 (phase1/2) prostate cancer clinical trials. The primary intent of the PCRP Clinical Consortium Award is to combine the efforts of leading investigators across multiple institutions to expedite the clinical advancement of novel therapeutic interventions in prostate cancer to decrease the impact of the disease. Distinctive Features: · This award mechanism does not support the development of clinical protocols. · Coordinating Center: This award mechanism supports one coordinating center, which will be responsible for development and maintenance of the consortium organizational structure, and also function as a Clinical Research Site. · Clinical Research Sites: This award mechanism supports multiple clinical research sites, which will be responsible for clinical trial introduction and selection, patient accrual for consortium studies, data collection and timely submissions, meeting attendance, and adherence to the consortium’s operating procedures.

## Questions people ask

### Is HT942525PCRPCCA still open?

No. It closed on September 2, 2025. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Prostate Cancer, Clinical Consortium Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD Prostate Cancer, Clinical Consortium Award?

Closed September 2, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $32.5 million in total across about 12 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.